Canonica, G., Poulsen, P., & Vestenbæk, U. (2007). Cost-effectiveness of GRAZAX ® for prevention of grass pollen induced rhinoconjunctivitis in Southern Europe. Respiratory medicine, 101(9), 1885-1894. https://doi.org/10.1016/j.rmed.2007.05.003
Citácia podle Chicago (17th ed.)Canonica, G.W, P.B Poulsen, a U. Vestenbæk. "Cost-effectiveness of GRAZAX ® for Prevention of Grass Pollen Induced Rhinoconjunctivitis in Southern Europe." Respiratory Medicine 101, no. 9 (2007): 1885-1894. https://doi.org/10.1016/j.rmed.2007.05.003.
Citácia podľa MLA (8th ed.)Canonica, G.W, et al. "Cost-effectiveness of GRAZAX ® for Prevention of Grass Pollen Induced Rhinoconjunctivitis in Southern Europe." Respiratory Medicine, vol. 101, no. 9, 2007, pp. 1885-1894, https://doi.org/10.1016/j.rmed.2007.05.003.